RSV vaccine boost in a new pregnancy
Treatments studied
Part of Infections clinical trials.
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old and pregnant with one baby (no twins).
- You are 24 to 36 weeks into your pregnancy.
- You got the RSVpreF or Abrysvo vaccine during a previous pregnancy.
- You have had a normal ultrasound at 18 weeks or later in this pregnancy.
- You are not currently breastfeeding and have a pre-pregnancy BMI of 40 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a booster dose of an experimental RSV vaccine (SCB-1019T) in healthy adults aged 60-85 who have already received the approved RSV vaccine AREXVY. The goal is to see if the booster is safe and boosts your immune system.
This study looks at how well RSV vaccines or antibody shots protect babies from severe respiratory infections. If your baby is under 1 year old, lives in Connecticut, and gets sick with a respiratory infection, they may be able to join.
This trial tests two ways to protect babies from RSV: a vaccine given to pregnant women, and an antibody shot given to newborns. Both are already approved—this study checks if using them together works better than either alone.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This registry follows pregnant people who received an RSV vaccine during a specific window (32 to 36 weeks) to monitor safety. If you got the shot in that time, your information helps researchers understand how well the vaccine works in pregnancy.
This trial tests if the RSVpreF vaccine given during pregnancy can help pass antibodies to the baby in women living with HIV. It may protect the infant from RSV, a common respiratory virus.
Hear when a new RSV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.